Literature DB >> 20433405

HIV-specific TGF-beta-positive CD4+ T cells do not express regulatory surface markers and are regulated by CTLA-4.

Mohamed Elrefaei1, Candace M Burke, Chris A R Baker, Norman G Jones, Stephanie Bousheri, David R Bangsberg, Huyen Cao.   

Abstract

CD4(+) T cell dysfunction in HIV-1 infection is associated with increased CTLA-4 and TGF-beta expression. In this study we described a population of TGF-beta-positive CD4(+) T cells with multiple HIV specificities. These HIV-specific TGF-beta-positive CD4(+) T cells did not display the immunophenotypic patterns traditionally attributed to regulatory CD4(+) T cells. TGF-beta-positive CD4(+) T cells were FOXP3 negative, CD25 negative, and displayed a heterogeneous surface expression of CD127. We also examined one potential mechanism for regulating TGF-beta expression by HIV-specific CD4(+) T cells. Blocking of the TGF-beta receptor II led to increased HIV-specific IFN-gamma-positive CD4(+) and CD8(+) T cell responses. Interestingly, HIV-specific TGF-beta-positive CD4(+) T cells did not substantially express CTLA-4. Nevertheless, CTLA-4 blockade resulted in a significant decrease in HIV-specific TGF-beta-positive CD4(+) T cell responses, and a concomitant increase in HIV-specific IFN-gamma-positive CD4(+) T cell responses. Our study proposes a mechanism by which HIV-specific TGF-beta production may be regulated by CTLA-4 engagement.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20433405      PMCID: PMC2933167          DOI: 10.1089/aid.2009.0149

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  50 in total

Review 1.  Mechanisms of suppression by suppressor T cells.

Authors:  Harald von Boehmer
Journal:  Nat Immunol       Date:  2005-04       Impact factor: 25.606

Review 2.  Transforming growth factor-beta in T-cell biology.

Authors:  Leonid Gorelik; Richard A Flavell
Journal:  Nat Rev Immunol       Date:  2002-01       Impact factor: 53.106

3.  CD4+CD25high regulatory cells in human peripheral blood.

Authors:  C Baecher-Allan; J A Brown; G J Freeman; D A Hafler
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

4.  Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses.

Authors:  M A Ostrowski; J X Gu; C Kovacs; J Freedman; M A Luscher; K S MacDonald
Journal:  J Infect Dis       Date:  2001-10-15       Impact factor: 5.226

5.  HIV antigens can induce TGF-beta(1)-producing immunoregulatory CD8+ T cells.

Authors:  Mohammed L Garba; Christopher D Pilcher; Andrea L Bingham; Joseph Eron; Jeffrey A Frelinger
Journal:  J Immunol       Date:  2002-03-01       Impact factor: 5.422

6.  CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention.

Authors:  Qibin Leng; Zvi Bentwich; Eli Magen; Alexander Kalinkovich; Gadi Borkow
Journal:  AIDS       Date:  2002-03-08       Impact factor: 4.177

7.  CD69+ CD4+ CD25- T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1.

Authors:  Yanmei Han; Qiuli Guo; Minggang Zhang; Zhubo Chen; Xuetao Cao
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

8.  Presence of suppressor HIV-specific CD8+ T cells is associated with increased PD-1 expression on effector CD8+ T cells.

Authors:  Mohamed Elrefaei; Chris A R Baker; Norman G Jones; David R Bangsberg; Huyen Cao
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

9.  CTLA-4 control over Foxp3+ regulatory T cell function.

Authors:  Kajsa Wing; Yasushi Onishi; Paz Prieto-Martin; Tomoyuki Yamaguchi; Makoto Miyara; Zoltan Fehervari; Takashi Nomura; Shimon Sakaguchi
Journal:  Science       Date:  2008-10-10       Impact factor: 47.728

10.  Modulation of susceptibility to HIV-1 infection by the cytotoxic T lymphocyte antigen 4 costimulatory molecule.

Authors:  J L Riley; K Schlienger; P J Blair; B Carreno; N Craighead; D Kim; R G Carroll; C H June
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

View more
  13 in total

Review 1.  Understanding HIV latency: the road to an HIV cure.

Authors:  Matthew S Dahabieh; Emilie Battivelli; Eric Verdin
Journal:  Annu Rev Med       Date:  2015       Impact factor: 13.739

2.  Effect of ipilimumab on the HIV reservoir in an HIV-infected individual with metastatic melanoma.

Authors:  Fiona Wightman; Ajantha Solomon; Sanjeev S Kumar; Nicolas Urriola; Kerri Gallagher; Bonnie Hiener; Sarah Palmer; Catriona Mcneil; Roger Garsia; Sharon R Lewin
Journal:  AIDS       Date:  2015-02-20       Impact factor: 4.177

3.  Cooperative regulation of NOTCH1 protein-phosphatidylinositol 3-kinase (PI3K) signaling by NOD1, NOD2, and TLR2 receptors renders enhanced refractoriness to transforming growth factor-beta (TGF-beta)- or cytotoxic T-lymphocyte antigen 4 (CTLA-4)-mediated impairment of human dendritic cell maturation.

Authors:  Devram Sampat Ghorpade; Srini V Kaveri; Jagadeesh Bayry; Kithiganahalli Narayanaswamy Balaji
Journal:  J Biol Chem       Date:  2011-07-15       Impact factor: 5.157

4.  Transforming growth factor-β1 regulated phosphorylated AKT and interferon gamma expressions are associated with epithelial cell survival in rhesus macaque colon explants.

Authors:  Bapi Pahar; Diganta Pan; Wendy Lala; Carys S Kenway-Lynch; Arpita Das
Journal:  Clin Immunol       Date:  2015-03-10       Impact factor: 3.969

Review 5.  Foxo3a: an integrator of immune dysfunction during HIV infection.

Authors:  Julien van Grevenynghe; Rafael A Cubas; Sandrina DaFonseca; Talibah Metcalf; Cecile L Tremblay; Lydie Trautmann; Rafick-Pierre Sekaly; John Schatzle; Elias K Haddad
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-27       Impact factor: 7.638

Review 6.  So Pathogenic or So What?-A Brief Overview of SIV Pathogenesis with an Emphasis on Cure Research.

Authors:  Adam J Kleinman; Ivona Pandrea; Cristian Apetrei
Journal:  Viruses       Date:  2022-01-12       Impact factor: 5.048

7.  Antiviral mode of action of bovine dialyzable leukocyte extract against human immunodeficiency virus type 1 infection.

Authors:  Humberto H Lara; Liliana Ixtepan-Turrent; Elsa N Garza-Treviño; Jose I Badillo-Almaraz; Cristina Rodriguez-Padilla
Journal:  BMC Res Notes       Date:  2011-11-01

Review 8.  Regulatory T Cells As Potential Targets for HIV Cure Research.

Authors:  Adam J Kleinman; Ranjit Sivanandham; Ivona Pandrea; Claire A Chougnet; Cristian Apetrei
Journal:  Front Immunol       Date:  2018-04-13       Impact factor: 7.561

Review 9.  Molecular signatures of T-cell inhibition in HIV-1 infection.

Authors:  Marie Larsson; Esaki M Shankar; Karlhans F Che; Alireza Saeidi; Rada Ellegård; Muttiah Barathan; Vijayakumar Velu; Adeeba Kamarulzaman
Journal:  Retrovirology       Date:  2013-03-20       Impact factor: 4.602

10.  Epidemiology and interactions of Human Immunodeficiency Virus - 1 and Schistosoma mansoni in sub-Saharan Africa.

Authors:  Humphrey D Mazigo; Fred Nuwaha; Shona Wilson; Safari M Kinung'hi; Domenica Morona; Rebecca Waihenya; Jorg Heukelbach; David W Dunne
Journal:  Infect Dis Poverty       Date:  2013-01-24       Impact factor: 4.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.